An Indian infant with de novo duplication of 16p chromosome: A rare genetic syndrome
How to cite this article: Goyal M, Gupta A, Faruq M, Shrivastava D. An Indian infant with de novo duplication of 16p chromosome: A rare genetic syndrome. Indian J Med Sci, doi: 10.25259/IJMS_278_2020
Facial dysmorphism along with multiple congenital anomalies is observed in many genetic syndromes mostly in chromosomal microdeletion or duplication, which cannot be detected by conventional karyotype. Here, we report a case with facial dysmorphism, cleft palate, congenital heart defect, and umbilical hernia, diagnosed with duplication at chromosome 16p13.3 by array comparative genomic hybridization (CGH) at very early age. Array CGH is the advanced diagnostic technology; enable to diagnose chromosomal abnormalities earlier thus can provide appropriate medical management and prognostication.
High resolution array comparative genomic hybridization (array CGH) has proven a powerful tool to detect submicroscopic chromosomal imbalance associated with development delay/ intellectual disability with or without facial dysmorphism. Low copy repeats (LCRs) mediated non-allelic homologous recombination leading to the occurrence of microdeletion/duplication syndrome. Short arm of chromosomal 16 (16p) is compassed of highly complex LCRs. 16p duplication syndrome is characterized by developmental delay, intellectual disability, growth and mental deficiency, facial dysmorphism, congenital heart, and urogenital anomalies. The most critical region is 16 p13.1–13.3 in determining the clinical manifestation.[3,4]
We hereby report a 2 months old girl with 6.1 Mb gain on Chromosome 16p13.3 by array CGH, presented with growth retardation, facial dysmorphism, cleft palate, umbilical hernia, congenital heart defect, seizures, and spasticity of the lower limb. Early detection and discovery of phenotype-genotype associations broadens the understanding of development of affected child and prognosticate the outcome.
A 2-month-old girl was referred for evaluation of facial dysmorphism. The child was first born of non-consanguineous parents with uneventful antenatal and perinatal period. She was born at term by normal vaginal delivery with birth weight of 2.4 kg. She was admitted on day 3 with excessive cry and abnormal movements of body, detected with hypocalcemic seizures. Anthropometric parameters at 2 months of age were weight 3.4 kg (<3rd centile), height 52cm (15th–25th centile), and head circumference 35 cm (<3 centile). Facial features suggested open anterior fontanel, hypertelorism, sparse eyebrows and eyelashes, broad nasal bridge and tip, bilateral ptosis, bilateral low set cup shape ears, long and prominent philtrum, downturned corner of mouth, micrognathia, and anterior cleft palate [Figure 1]. There were bilateral simian crease and clinodactyly. Small umbilical hernia was present. Her tone in lower limb was increased and reflexes were present. Echocardiography suggested atrial septal defect (ASD). Ultrasonography abdomen and MRI brain were normal. Chromosomal analysis by karyotype and FISH analysis for 22q11.2 microdeletion was normal. Blood sample was sent for array CGH in EDTA vial. Cytogenetic study was conducted using Affymetrix CytoScan 750 K array (Affymetrix Inc., Santa Clara, CA, USA), revealed a 6.1 Mb gain in the 16p13.3 region [Figure 2]. This region comprising 146 OMIM genes include critical gene CREBBP. Chromosome analyses of both parents were normal, considering de novo change in the child.
The cytogenomic array CGH analysis showed a gain involving chromosome 16p13.3, indicating duplication in this region. The region overlaps the previously described 16p13.3 duplication syndrome and contains the 146 OMIM genes including critical gene CREBBP. Features described in previously affected individuals include growth and mental retardation, specific facial appearance with round head, upslanting and narrow palpebral fissures, sparse eyebrows, broad nasal bridge, rounded nasal tip, prominent glabella, long philtrum, thin upper lip, and micrognathia that changes with age, palatal defects, digital, and musculoskeletal anomalies (club feet, congenital hip dislocation, or camptodactyly of the fingers and toes), anomalies of the heart (ASD, tetralogy of Fallot), and urogenital system.[5,6] The facial features of our patient were similar to those of the reported cases. The previous studies demonstrated that the phenotypic severity could not be related to the size of the duplicated segment.
In our patient, ASD of 3 mm was present. Patients with large 16p duplications have been reported with ASD, tetralogy of Fallot or ventricular septal defect or early onset of pulmonary vascular disease.[7,8] Thus, a baseline cardiological evaluation and periodic monitoring for the potential onset of pulmonary hypertension are recommended.
Seizures and spasticity were present in our case without structural CNS anomalies. McDigillo et al. described two cases with duplication 16p along with review of previously published nine cases. They found neurological manifestations such as seizures in 5/11 cases, corpus callosum hypoplasia in 3/8 cases, and microcephaly in 6/11 cases. The urinary anomalies described in the literature were not found in our case.
This variability of symptoms may present need of characterization of the phenotypic variation of such genetic syndromes at different deletion sizes to improve the clinical diagnosis and management. Microarray offers a genome-wide analysis allowing detection of deletions and duplications thus improving the yield of diagnostic test.
Early diagnosis of 16p duplication in pediatric patients with multiple congenital anomalies helps to optimize a multidisciplinary treatment approach. Delay in diagnosis could lead to financial burden and unfavorable outcomes. The confirmation of diagnosis is crucial for prognostication, and to provide recurrence risk for future pregnancy in the family.
We have confirmed the existence of a rare genetic syndrome in a child with duplication 16p, involving the 13.3 region. Facial dysmorphism, growth and mental deficiency, digital, and heart abnormalities are clinical clues for suspecting this rare syndrome, which can be confirmed by newer molecular cytogenetic testing methods. Neurologic deficit such as seizures and spasticity, as occurring in our case, can be a feature of dup16p. Increased awareness of the advanced genomic technologies such as array CGH may enable clinicians to diagnose such disorders and provide prognosis and course of disease and for preconceptional genetic counseling.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.